• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Thermo Fisher Scientific Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    9/2/25 8:03:06 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials
    Get the next $TMO alert in real time by email
    tmo-20250901
    0000097745FALSE00000977452025-09-012025-09-010000097745us-gaap:CommonStockMember2025-09-012025-09-010000097745tmo:SeniorNotes3200Due2026Member2025-09-012025-09-010000097745tmo:SeniorNotes1.40Due2026Member2025-09-012025-09-010000097745tmo:A1.45SeniorNotesDue2027Member2025-09-012025-09-010000097745tmo:SeniorNotes175Due2027Member2025-09-012025-09-010000097745tmo:SeniorNotes0.500Due2028Member2025-09-012025-09-010000097745tmo:SeniorNotes1.375Due2028Member2025-09-012025-09-010000097745tmo:SeniorNotes1.95Due2029Member2025-09-012025-09-010000097745tmo:SeniorNotes0.875Due2031Member2025-09-012025-09-010000097745tmo:SeniorNotes2375Due2032Member2025-09-012025-09-010000097745tmo:SeniorNotes3650Due2034Member2025-09-012025-09-010000097745tmo:SeniorNotes2.875Due2037Member2025-09-012025-09-010000097745tmo:SeniorNotes1.500Due2039Member2025-09-012025-09-010000097745tmo:SeniorNotes1.875Due2049Member2025-09-012025-09-01



    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): September 1, 2025

    THERMO FISHER SCIENTIFIC INC.
    (Exact name of Registrant as specified in its Charter)
    Delaware1-800204-2209186
    (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

    168 Third Avenue
    Waltham, Massachusetts 02451
    (Address of principal executive offices) (Zip Code)

    Registrant’s telephone number, including area code: (781) 622-1000
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, $1.00 par valueTMONew York Stock Exchange
    3.200% Notes due 2026TMO 26BNew York Stock Exchange
    1.400% Notes due 2026TMO 26ANew York Stock Exchange
    1.450% Notes due 2027TMO 27New York Stock Exchange
    1.750% Notes due 2027TMO 27BNew York Stock Exchange
    0.500% Notes due 2028TMO 28ANew York Stock Exchange
    1.375% Notes due 2028TMO 28New York Stock Exchange
    1.950% Notes due 2029TMO 29New York Stock Exchange
    0.875% Notes due 2031TMO 31New York Stock Exchange
    2.375% Notes due 2032TMO 32New York Stock Exchange
    3.650% Notes due 2034TMO 34New York Stock Exchange
    2.875% Notes due 2037TMO 37New York Stock Exchange
    1.500% Notes due 2039TMO 39New York Stock Exchange
    1.875% Notes due 2049TMO 49New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐  

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐






    Item 8.01    Other Events.

    On September 2, 2025, Thermo Fisher Scientific Inc. (“Thermo Fisher”) issued a press release announcing the completion of its acquisition of Solventum Corporation’s purification and filtration business. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

    Item 9.01    Financial Statements and Exhibits.

    (d)    Exhibits

    99.1    Press Release of Thermo Fisher Scientific Inc., dated September 2, 2025.
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)



    2





    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    THERMO FISHER SCIENTIFIC INC.
    Date:September 2, 2025By:/s/ Thomas B. Shropshire
    Thomas B. Shropshire
    Senior Vice President and General Counsel

    3
    Get the next $TMO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TMO

    DatePrice TargetRatingAnalyst
    9/11/2025$550.00Equal Weight → Overweight
    Barclays
    8/19/2025Outperform
    William Blair
    7/24/2025$510.00Buy → Hold
    HSBC Securities
    7/11/2025$590.00Sector Perform → Sector Outperform
    Scotiabank
    7/9/2025$460.00Buy → Neutral
    UBS
    1/10/2025$630.00Mkt Perform → Outperform
    Bernstein
    12/23/2024Sector Perform
    Scotiabank
    10/14/2024Buy
    Redburn Atlantic
    More analyst ratings

    $TMO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Thermo Fisher upgraded by Barclays with a new price target

    Barclays upgraded Thermo Fisher from Equal Weight to Overweight and set a new price target of $550.00

    9/11/25 8:36:39 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    William Blair initiated coverage on Thermo Fisher

    William Blair initiated coverage of Thermo Fisher with a rating of Outperform

    8/19/25 8:36:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Thermo Fisher from Buy to Hold and set a new price target of $510.00

    7/24/25 9:29:26 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Weisler Dion J

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    9/30/25 4:19:32 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Director Sperling Scott M

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    9/30/25 4:17:08 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Director Keith R. Alexandra

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    9/30/25 4:14:52 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Chai Nelson sold $8,449 worth of shares (16 units at $528.09) and bought $11,038 worth of shares (20 units at $551.90), increasing direct ownership by 0.03% to 14,252 units (SEC Form 4)

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    2/21/25 4:19:32 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Boxer Michael A bought $2,105 worth of shares (4 units at $526.15), increasing direct ownership by 0.03% to 13,101 units (SEC Form 4)

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    10/6/23 4:23:51 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    SEC Filings

    View All

    Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)

    10/22/25 6:05:30 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)

    10/7/25 4:30:59 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    SEC Form 424B5 filed by Thermo Fisher Scientific Inc

    424B5 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)

    10/1/25 5:03:50 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Thermo Fisher Scientific Reports Third Quarter 2025 Results

    Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 27, 2025. Third Quarter Highlights Third quarter revenue grew 5% to $11.12 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.27, in-line with the prior-year quarter. Third quarter adjusted EPS grew 10% to $5.79. Delivered excellent operational performance in the quarter demonstrating the strength of our proven growth strategy, the power of our PPI Business System, and the continued active management of our company. Advanced our proven growth strategy, launching a range of high-impact, innovative new p

    10/22/25 6:00:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI

    Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher's proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines to patients faster and more cost effectively. Working with OpenAI, Thermo Fisher is focusing on accelerating scientific innovation, enhancing productivity and reducing complexity. As part of this collaboration, Thermo Fisher is embedding Open AI APIs (Application Programming Interfaces) into critical areas of its business - ranging from product de

    10/16/25 8:00:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025

    Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2025 before the market opens on Wednesday, October 22, 2025, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. The access code is 761271. You may also listen to the call live on the "Investors" section of our website, www.thermofisher.com. The earnings press release and related information can also be found in that section of our website under

    10/1/25 8:00:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Leadership Updates

    Live Leadership Updates

    View All

    Thermo Fisher Scientific's Chief Financial Officer, Stephen Williamson, to Retire in Early 2026

    Jim Meyer to Become Chief Financial Officer, Effective March 1, 2026 Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial officer (CFO), has decided to retire from the company, effective March 31, 2026. The company's board of directors has approved the appointment of Jim Meyer, currently vice president of financial operations, to succeed Williamson as CFO, effective March 1, 2026. Williamson, age 58, has led Thermo Fisher's global finance organization as CFO since 2015. He joined the company in 2001 as Vice President, European Financial Operations. To ensure a seamless transition

    7/23/25 9:00:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    908 Devices Appoints Christopher D. Brown to its Board of Directors

    908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead

    6/16/25 8:00:00 AM ET
    $AAPL
    $MASS
    $RGEN
    Computer Manufacturing
    Technology
    Industrial Machinery/Components
    Industrials

    GeminiBio Appoints Mike Stella to Board

    Strengthening Board with Industry Veterans Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based healthcare private equity firm, announced today the appointment of Michael Stella to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218608576/en/Mike Stella, CEO of Ascend Advanced Therapies, joins the Board at GeminiBio to provide strategic leadership in the fields of cell and gene therapy contract development and manufacturing. (Photo: Business Wire) GeminiBio prov

    2/18/25 9:00:00 AM ET
    $AMGN
    $GSK
    $JNJ
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    $TMO
    Financials

    Live finance-specific insights

    View All

    Thermo Fisher Scientific Reports Third Quarter 2025 Results

    Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 27, 2025. Third Quarter Highlights Third quarter revenue grew 5% to $11.12 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.27, in-line with the prior-year quarter. Third quarter adjusted EPS grew 10% to $5.79. Delivered excellent operational performance in the quarter demonstrating the strength of our proven growth strategy, the power of our PPI Business System, and the continued active management of our company. Advanced our proven growth strategy, launching a range of high-impact, innovative new p

    10/22/25 6:00:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025

    Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2025 before the market opens on Wednesday, October 22, 2025, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. The access code is 761271. You may also listen to the call live on the "Investors" section of our website, www.thermofisher.com. The earnings press release and related information can also be found in that section of our website under

    10/1/25 8:00:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific Reports Second Quarter 2025 Results

    Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 28, 2025. Second Quarter Highlights Second quarter revenue grew 3% to $10.85 billion. Second quarter GAAP diluted earnings per share (EPS) grew 6% to $4.28. Second quarter adjusted EPS was $5.36. Delivered excellent operational performance in the quarter, reflecting active management of our company in the macroenvironment demonstrating the strength of our proven growth strategy and the power of the PPI Business System. Advanced our proven growth strategy, launching a range of high-impact innovation, strengthening our industr

    7/23/25 6:00:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Thermo Fisher Scientific Inc (Amendment)

    SC 13G/A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)

    2/9/23 11:35:13 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed

    SC 13G/A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)

    2/10/21 11:57:23 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials